Powered by MOMENTUM MEDIA

Website Notifications

Get notifications in real-time for staying up to date with content that matters to you.

Call to arms for SMEs for JP 2060 Phase 4

ran medical school simulation
Image via Commonwealth of Australia, Department of Defence.

With Gate 2 for Defence’s JP 2060 Phase 3 Deployable Health Capability expected by the end of this year, one bidder for the project has turned its sights to engaging Australian industry for its Phase 4 offering.

With Gate 2 for Defence’s JP 2060 Phase 3 Deployable Health Capability expected by the end of this year, one bidder for the project has turned its sights to engaging Australian industry for its Phase 4 offering.

Leidos Australia has confirmed it is planning to submit a response to the recently released Commonwealth request for information (RFI) and the subsequently anticipated quarter 4, 2018 request for tender (RFT) for the JP2060 Phase 4  Health Knowledge Management (HKM) Project.

Advertisement
Advertisement

Phase 4 is one part of the multi-phase joint project (JP) being led by the Capability Acquisition and Sustainment Group (CASG) within the Australian Department of Defence, which involves the identification and development of capabilities required to prevent, treat, manage and evacuate casualties in joint operations in the defence of Australia and its interests.

The JP2060 Phase 4 HKM Project will acquire and sustain a commercial, information technology (IT), enterprise knowledge solution that captures health data and collates and manages the information across the Australian Defence Force health care continuum within the deployed and non-deployed, garrison environment.

Defence said the solution will be required to provide greater healthcare business functionality, utilise an efficient health informatics process and enable efficient and safe, evidenced based, patient-centric care. The HKM solution will be required to interface with Defence ICT platforms, allied coalition partners, Australian healthcare providers and nominated government agencies.

The HKM solution will be a predominately commercial off-the-shelf solution that meets Australian Clinical Practice Guidelines. The primary capabilities that Leidos Australia are seeking support from Australian industry on in relation to the JP2060 Phase 4 HKM Project include: dental software and applications, pharmaceutical software and applications, health analytics, decision support, hazard and threat modelling, and veterinarian software and applications.

In a letter to the Australian Industry & Defence Network, Leidos Australia said it "would like to maximise the opportunities available for competitive Australian industry to be considered for participation in Leidos Australia’s response for this project".

PROMOTED CONTENT

The letter from Leidos also encouraged SMEs and Indigenous businesses interested in being part of its bid to register their interest on the Leidos website.

Call to arms for SMEs for JP 2060 Phase 4
RAN-Medical-school-simulation-.jpg
lawyersweekly logo

more from defence connect

Jan 25 2022
Defence opens hypersonics research precinct
A new purpose-built facility has been unveiled in Brisbane, designed to house research into the development of sovereign long-rang...
ULAQ
Jan 25 2022
Turkey’s ‘ULAQ’ armed unmanned surface vehicle completes new weapon system firing tests
Antalya-based ARES Shipyard and Ankara-based Meteksan Defense successfully completed the firing tests by integrating a 12.7mm remo...
Jan 25 2022
Northrop Grumman deploys next-gen autonomous helicopter
The prime’s ship-based autonomous helicopter has officially been deployed with the US Navy. ...